Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001137439-25-000540·AEON Biopharma, Inc.
Schedule 13G ownership disclosure
AEON BIOPHARMA INC
Common · CUSIP: 00791X209
Event date: 2025-05-27
- Filing-level shares
- 1,128,500.00
- Percent of class
- 9.9%
- Chernett Jorey
Shares: 1,128,500.00 · Class: 9.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001137439-25-000540
- Form type
- SCHEDULE 13G
- Filer
- AEON Biopharma, Inc.
- CIK
- CIK 1837607
- Filed
- May 30, 2025
- Reporting period
- May 27, 2025
- Description
- Schedule 13G beneficial ownership